Pilot Study of Neoadjuvant Chemotherapy Combined With Immunotherapy and Multimodal Thermal Therapy for HER2-negative Breast Cancer

NCT06636591 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer Female
HER2-negative Breast Cancer

Interventions

COMBINATION_PRODUCT: Device: Multimodal Tumor Thermal Therapy System Drug: Camrelizumab Drug: Nab paclitaxel Drug: Carboplatin
COMBINATION_PRODUCT: Device: Multimodal Tumor Thermal Therapy System Drug: Camrelizumab Drug: Nab paclitaxel Drug: Carboplatin Drug: Goserelin

Sponsor

Fudan University